AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition – Meet them this November

Talawar Therapeutics Heads to Nasdaq via SPAC Deal to Bankroll Eczema Asset

10 Clinical Trials to Watch Out for in the latter half of 2026 – Read here

Akero execs reunite to advance long-acting psoriasis pill

Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug

InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test

Sanofi halts development of troubled immune drug in eczema

Establishing New Market Entrants to Compete Effectively & Drive Adoption

3:30 pm - Thursday 5th November 2026

Developing strategies for market entry, reducing launch barriers, to accelerate uptake
Differentiating products in competitive landscapes, enhancing visibility, to win market share
Overcoming adoption challenges, aligning with stakeholder needs, to drive commercial success

Christoph Wulf

Vice President & Head of Commercial

Nielsen BioSciences